De Chiara, L.; Barcia-Castro, L.; Gallardo-Gómez, M.; Páez de la Cadena, M.; MartÃnez-Zorzano, V.S.; RodrÃguez-Berrocal, F.J.; Bujanda, L.; Etxart, A.; Castells, A.; Balaguer, F.;
et al. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs. Cancers 2022, 14, 4563.
https://doi.org/10.3390/cancers14194563
AMA Style
De Chiara L, Barcia-Castro L, Gallardo-Gómez M, Páez de la Cadena M, MartÃnez-Zorzano VS, RodrÃguez-Berrocal FJ, Bujanda L, Etxart A, Castells A, Balaguer F,
et al. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs. Cancers. 2022; 14(19):4563.
https://doi.org/10.3390/cancers14194563
Chicago/Turabian Style
De Chiara, Loretta, Leticia Barcia-Castro, MarÃa Gallardo-Gómez, MarÃa Páez de la Cadena, Vicenta S. MartÃnez-Zorzano, Francisco J. RodrÃguez-Berrocal, Luis Bujanda, Ane Etxart, Antoni Castells, Francesc Balaguer,
and et al. 2022. "Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs" Cancers 14, no. 19: 4563.
https://doi.org/10.3390/cancers14194563
APA Style
De Chiara, L., Barcia-Castro, L., Gallardo-Gómez, M., Páez de la Cadena, M., MartÃnez-Zorzano, V. S., RodrÃguez-Berrocal, F. J., Bujanda, L., Etxart, A., Castells, A., Balaguer, F., Jover, R., Cubiella, J., & Cordero, O. J.
(2022). Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs. Cancers, 14(19), 4563.
https://doi.org/10.3390/cancers14194563